The role of FOXO transcription factors in the development of type 2 diabetes and related potential therapeutic possibilities

被引:4
|
作者
Bielka, Weronika [1 ]
Przezak, Agnieszka [1 ]
机构
[1] Pomorski Uniwersytet Med, Szczecin, Poland
来源
CLINICAL DIABETOLOGY | 2021年 / 10卷 / 03期
关键词
diabetes; FOXO transcription factors; beta-cell failure; glucose metabolism; lipid metabolism; insulin signalling pathway; oxidative stress; INSULIN SENSITIVITY; GENE-EXPRESSION; HEPATIC GLUCONEOGENESIS; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; LIFE-SPAN; APOC-III; PROTEINS; GLUCOSE; ACTIVATION;
D O I
10.5603/DK.a2021.0021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Forkhead box class O (FOXO) family member proteins are key transcription factors for maintaining the intracellular homeostasis in response to changes in the internal and external environment. They participate in the control of such cellular processes as proliferation, cell cycle, apoptosis, glucose and lipid metabolism, and oxidative stress response. Altered expression and activity of these factors are associated with development of metabolic disturbances, primarily type 2 diabetes. Understanding of the role of FOXO in the pathophysiology of these abnormalities will enable appropriate steps to prevent their development and to create therapies targeted at the disturbances underlying type 2 diabetes and metabolic syndrome. In the present article, we summarized the current knowledge about the physiology and pathophysiology of these transcription factors and described their role in the development of diabetes and functioning of various organs. We focused on their role in progression of diabetes and indicated potential targets for future therapeutic interventions.
引用
收藏
页码:290 / 298
页数:9
相关论文
共 50 条
  • [11] Nicotinamide overload may play a role in the development of type 2 diabetes
    Zhou, Shi-Sheng
    Li, Da
    Sun, Wu-Ping
    Guo, Ming
    Lun, Yong-Zhi
    Zhou, Yi-Ming
    Xiao, Fu-Cheng
    Jing, Li-Xin
    Sun, Shen-Xia
    Zhang, Li-Bin
    Luo, Ning
    Bian, Fu-Ning
    Zou, Wei
    Dong, Lai-Bin
    Zhao, Zhi-Gang
    Li, Sheng-Fan
    Gong, Xiao-Jie
    Yu, Zeng-Guo
    Sun, Chang-Bin
    Zheng, Cong-Long
    Jiang, Dong-Ju
    Li, Zheng-Ning
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (45) : 5674 - 5684
  • [12] Role of Caveolae in the Development of Microvascular Dysfunction and Hyperglycemia in Type 2 Diabetes
    Tian, Yanna
    Fopiano, Katie Anne
    Patel, Vijay S.
    Feher, Attila
    Bagi, Zsolt
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [13] The role of insulin signaling with FOXO and FOXK transcription factors
    Sakaguchi, Masaji
    ENDOCRINE JOURNAL, 2024, 71 (10) : 939 - 944
  • [14] Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis
    Farhan, Mohd
    Silva, Marta
    Xing Xingan
    Yu Huang
    Zheng, Wenhua
    CELLS, 2020, 9 (07) : 1 - 18
  • [15] Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update
    Palmer, Ethan S.
    Irwin, Nigel
    O'Harte, Finbarr P. M.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2022, 15
  • [16] Remote ischemic conditioning: A potential therapeutic strategy of type 2 diabetes
    Liu, Jie
    Sun, Xin
    Jin, Hang
    Yan, Xiu-Li
    Huang, Shuo
    Guo, Zhen-Ni
    Yang, Yi
    MEDICAL HYPOTHESES, 2021, 146
  • [17] The multifaceted function of FoxO1 in pancreatic β-cell dysfunction and insulin resistance: Therapeutic potential for type 2 diabetes
    Wang, Hongyu
    Bai, Ran
    Wang, Yubing
    Qu, Meihua
    Zhou, You
    Gao, Zhiqin
    Wang, Yi
    LIFE SCIENCES, 2025, 364
  • [18] Natural activators of AMPK signaling: potential role in the management of type-2 diabetes
    Chauhan, Sanyogita
    Singh, Aakash Partap
    Rana, Avtar Chand
    Kumar, Sunil
    Kumar, Ravi
    Singh, Jitender
    Jangra, Ashok
    Kumar, Dinesh
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) : 47 - 59
  • [19] FOXO transcription factors as therapeutic targets in human diseases
    Orea-Soufi, Alba
    Paik, Jihye
    Braganca, Jose
    Donlon, Timothy A.
    Willcox, Bradley J.
    Link, Wolfgang
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (12) : 1070 - 1084
  • [20] Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes
    Vezza, Teresa
    Abad-Jimenez, Zaida
    Marti-Cabrera, Miguel
    Rocha, Milagros
    Victor, Victor Manuel
    ANTIOXIDANTS, 2020, 9 (09) : 1 - 21